Twitxy Saved

Praveen D. Chatani, MD

@ChataniMD

CGSO Fellow @FoxChaseCancer | Prior @RWJsurgery Resident & @NCI_SurgOncFel Immunotherapy Research Fellow | Product of Jamaica 🇯🇲
Philadelphia, PA Joined July 2018
713 Following 653 Followers 301 Posts

Latest posts 5

Praveen D. Chatani, MD @ChataniMD
Grateful to @CureMelanoma and its donors for supporting melanoma research.
Melanoma Research Foundation Verified account @CureMelanoma Jul 22
#MRFResearchWednesday -- Today, we proudly recognize Praveen Chatani, MD of @Foxchasecancer, recipient of a 2026 MRF Resident/Fellow Award generously funded through Gracie's Grant.

Dr. Chatani's research project titled, "Non-invasive Assessment of Response to Neoadjuvant Therapy in cN+ Melanoma," explores the accuracy of needle biopsies as a viable option for patients to avoid extensive lymph node surgery, reducing potential complications and improving quality of life. Dr. Chatani's work could provide key data to support larger #ClinicalTrials to make melanoma care safer and more personalized.

Related to his work, Dr. Chatani offers, "Immunotherapy given before surgery can be remarkably effective against melanoma, and how well a patient responds helps shape every decision that follows. The challenge is that measuring this response usually requires a surgery to examine the tissue directly. Our research is testing whether non-invasive tools — a blood test for tumor DNA, a PET scan, or a small needle biopsy — can predict that response just as reliably. If they can, we could assess a patient's response to treatment without an operation, tailoring their next steps sooner and more gently. We want to give patients clearer answers about their cancer with the least invasive testing possible.”

To learn more about this research, visit -- melanoma.org/news-press/res…
View quoted post on X
1 replies 1 reposts 9 likes 1.3K views View on X
Praveen D. Chatani, MD @ChataniMD
Phenomenal podcast filled with pearls from leaders of a high-volume TIL program. A must-listen for anyone looking to build/develop one of their own.
New episode of SurgOnc Today🎙️

Drs. Amanda Kirane and Allison Betof discuss the clinical application of TIL therapy for melanoma patients, including the comprehensive care and teamwork required.

Listen now: ow.ly/n57b50Z7CYo
View quoted post on X
Praveen D. Chatani, MD @ChataniMD
Thanks for the shoutout @SSATNews. I have grown so much and established many professional relationships through the Resident and Fellow Education Committee. Highly recommend getting involved!
SSAT @SSATNews Nov 6, 2025
Meet Dr. Prav Chatani (@ChataniMD), Complex General Surgical Oncology fellow at @FoxChaseCancer.

From training at @RWJsurgery to engaging with mentors like @AMVillanoMD and @JeffreyFarma, Dr. Chatani exemplifies leadership in academic surgery.

#SSAT #SurgicalOncology
View quoted post on X
0 replies 0 reposts 12 likes 1.3K views View on X
Praveen D. Chatani, MD @ChataniMD
Whether or not you seek a career in clinical trials, understanding the where/how of trial development and, at a minimum, developing an appreciation for its difficulty, is a prerequisite for a career in medicine. So grateful to @MichaelDAngeli2 and @SyedAAhmad5 for making time.
SSAT @SSATNews Sep 15, 2025
Mentor of the Month

Dr. @ChataniMD & @rajarnarayan interview @SyedAAhmad5 & @MichaelDAngeli2 on the future of surgeon-led clinical trials discussing key issues of data, centralization & funding.

Watch now: ow.ly/ANuz50WX84K

@ZhiVenFongMD
View quoted post on X